News-Papers
Testimonial
Video Gallery
Clinical importance of melatonin
Published on Tuesday, 26 June 2018
Clinical importance of melatonin
See also:
- The Di Bella Method (A Fixed Part - Melatonin tablets);
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Does the use of melatonin overcome drug resistance in cancer chemotherapy?
- Adjuvant chemotherapy with melatonin for targeting human cancers: A review
- A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin
- Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies
- Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids
- Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
- Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- Melatonin in cancer management: progress and promise
- Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
- Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
- Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
- The impact of vitamin D on cancer: A mini review
- Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
- Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
- Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
- Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
- Melatonin: an endogenous miraculous indolamine, fights against cancer progression
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer